This topic contains a solution. Click here to go to the answer

Author Question: When developing a plan of care for a group of men experiencing erectile dysfunction, which of the ... (Read 56 times)

itsmyluck

  • Hero Member
  • *****
  • Posts: 546
When developing a plan of care for a group of men experiencing erectile dysfunction, which of the following would the nurse expect to institute first?
 
  A) Lifestyle changes
  B) Adjustments to current medications
  C) Psychotherapy
  D) Behavior modification

Question 2

A patient comes to the community health clinic with complaints of changes in urination. Which of the following would lead the community health nurse to suspect that the patient has benign prostatic hypertrophy (BPH)?
 
  A) Nighttime frequency
  B) Dysuria
  C) Hematuria
  D) Flank pain



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dinolord

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

A

Answer to Question 2

A




itsmyluck

  • Member
  • Posts: 546
Reply 2 on: Jul 8, 2018
Wow, this really help


cici

  • Member
  • Posts: 325
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library